Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TEXAS INSTRUMENTS INCTXN · Entity 2834 | Sr. Vice President & CFO | May 14, 2026 | May 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TEXAS INSTRUMENTS INC
Report date May 14, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 85,485 |
Ending reported balance
After 2026-05-14 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-05-14 · Exercise / conversion · Acquired 47,734 · Balance 133,219 Row 2 · 2026-05-14 · Sale · Disposed 32,119 · Balance 101,100 F1: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $307.29 to $308.29. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Row 3 · 2026-05-14 · Sale · Disposed 14,156 · Balance 86,944 F2: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $308.30 to $309.16. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Row 4 · 2026-05-14 · Sale · Disposed 1,459 · Balance 85,485 F3: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.32 to $309.80. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| NQ Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $174.81 · Expires 2032-01-27 | Direct | 0 |
Reported balance
After 2026-05-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-05-14 · Exercise / conversion · Disposed 47,734 · Balance 0 F4: The option became exercisable in four equal annual installments beginning on January 27, 2023. |
| Common StockSEC Table I · non-derivative | IndirectSLAT | 33,994 |
Reported balance
Holding disclosure · report date 2026-05-14 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 33,994 |
Filing footnotes · ownership attribution and instrument terms
F1: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $307.29 to $308.29. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F2: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $308.30 to $309.16. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F3: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.32 to $309.80. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F4: The option became exercisable in four equal annual installments beginning on January 27, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 15, 2026 20:46 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 47,734 | $0.00 Strike: $174.81 | $0.00 |
DisclosureSEC source: 0000097476-26-000140 · wk-form4_1778877972.xml · derivative · entry 6 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,734 shares Expires 2032-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in four equal annual installments beginning on January 27, 2023. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:46 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 1,459 | $309.45 | $451,485.65 |
DisclosureSEC source: 0000097476-26-000140 · wk-form4_1778877972.xml · nonDerivative · entry 4 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,485 F3 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.32 to $309.80. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:46 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 14,156 | $308.54 | $4,367,760.19 |
DisclosureSEC source: 0000097476-26-000140 · wk-form4_1778877972.xml · nonDerivative · entry 3 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,944 F2 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $308.30 to $309.16. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:46 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 32,119 | $307.85 | $9,887,750.64 |
DisclosureSEC source: 0000097476-26-000140 · wk-form4_1778877972.xml · nonDerivative · entry 2 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,100 F1 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $307.29 to $308.29. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:46 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionCommon Stock | 47,734 | $174.81 | $8,344,380.54 |
DisclosureSEC source: 0000097476-26-000140 · wk-form4_1778877972.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:31 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 40,541 | $0.00 Strike: $169.23 | $0.00 |
DisclosureSEC source: 0000097476-26-000111 · wk-form4_1777321879.xml · derivative · entry 6 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,541 shares Expires 2031-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in four equal annual installments beginning on January 28, 2022. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:31 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 2,419 | $275.53 | $666,513.84 |
DisclosureSEC source: 0000097476-26-000111 · wk-form4_1777321879.xml · nonDerivative · entry 4 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,485 F3 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $275.285 to $275.79. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:31 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 16,057 | $274.70 | $4,410,914.10 |
DisclosureSEC source: 0000097476-26-000111 · wk-form4_1777321879.xml · nonDerivative · entry 3 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,904 F2 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $274.22 to $275.195. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:31 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 22,065 | $273.74 | $6,040,128.26 |
DisclosureSEC source: 0000097476-26-000111 · wk-form4_1777321879.xml · nonDerivative · entry 2 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,961 F1 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $273.22 to $274.21. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:31 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionCommon Stock | 40,541 | $169.23 | $6,860,753.43 |
DisclosureSEC source: 0000097476-26-000111 · wk-form4_1777321879.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 21:25 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 7,096 | $230.78 | $1,637,611.33 |
DisclosureSEC source: 0000097476-26-000069 · wk-form4_1770931549.xml · nonDerivative · entry 4 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,454 F3 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $230.51 to $231.005. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:25 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 64,532 | $0.00 Strike: $130.52 | $0.00 |
DisclosureSEC source: 0000097476-26-000069 · wk-form4_1770931549.xml · derivative · entry 6 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,532 shares Expires 2030-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in four equal annual installments beginning on January 24, 2021. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:25 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 20,477 | $221.22 | $4,529,948.56 |
DisclosureSEC source: 0000097476-26-000069 · wk-form4_1770931549.xml · nonDerivative · entry 3 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,550 F2 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $220.89 to $221.63. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:25 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 44,055 | $220.51 | $9,714,590.08 |
DisclosureSEC source: 0000097476-26-000069 · wk-form4_1770931549.xml · nonDerivative · entry 2 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,027 F1 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $219.89 to $220.88. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:25 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionCommon Stock | 64,532 | $130.52 | $8,422,716.64 |
DisclosureSEC source: 0000097476-26-000069 · wk-form4_1770931549.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 21:24 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Tax withholdingCommon Stock | 3,773 | $218.97 | $826,173.81 |
DisclosureSEC source: 0000097476-26-000050 · wk-form4_1770067490.xml · nonDerivative · entry 2 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,550 Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:24 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 44,488 | $0.00 Strike: $218.97 | $0.00 |
DisclosureSEC source: 0000097476-26-000050 · wk-form4_1770067490.xml · derivative · entry 4 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,488 Underlying: Common Stock · 44,488 shares Expires 2036-01-29 F2 · derivative.exercise_date: The stock option becomes exercisable in four equal installments beginning on January 29, 2027. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:24 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 12,559 | $0.00 | $0.00 |
DisclosureSEC source: 0000097476-26-000050 · wk-form4_1770067490.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,323 F1 · shares: Award of restricted stock units pursuant to 2024 Long-Term Incentive Plan. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 21:55 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Tax withholdingCommon Stock | 3,283 | $185.27 | $608,241.41 |
DisclosureSEC source: 0001127602-25-002771 · form4.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,641 Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 21:48 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 53,246 | $0.00 Strike: $187.03 | $0.00 |
DisclosureSEC source: 0001127602-25-002283 · form4.xml · derivative · entry 3 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,246 Underlying: Common Stock · 53,246 shares Expires 2035-01-27 F2 · derivative.exercise_date: The stock option becomes exercisable in four equal installments beginning on January 27, 2026. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 21:48 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 12,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-002283 · form4.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,924 F1 · shares: Award of restricted stock units pursuant to 2024 Long-Term Incentive Plan. Read SEC document |
| November 07, 2024 Filed Nov 13, 2024 21:21 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 33,996 | $0.00 Strike: $104.41 | $0.00 |
DisclosureSEC source: 0001127602-24-027217 · form4.xml · derivative · entry 6 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,996 shares Expires 2029-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 25, 2020. Read SEC document |
| November 07, 2024 Filed Nov 13, 2024 21:21 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 12,921 | $0.00 Strike: $110.15 | $0.00 |
DisclosureSEC source: 0001127602-24-027217 · form4.xml · derivative · entry 5 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,921 shares Expires 2028-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in four equal annual installments beginning on January 25, 2019. Read SEC document |
| November 07, 2024 Filed Nov 13, 2024 21:21 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 46,917 | $217.16 | $10,188,293.98 |
DisclosureSEC source: 0001127602-24-027217 · form4.xml · nonDerivative · entry 3 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,061 F1 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $216.7 to $217.61. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| November 07, 2024 Filed Nov 13, 2024 21:21 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionCommon Stock | 33,996 | $104.41 | $3,549,522.36 |
DisclosureSEC source: 0001127602-24-027217 · form4.xml · nonDerivative · entry 2 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2024 Filed Nov 13, 2024 21:21 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionCommon Stock | 12,921 | $110.15 | $1,423,248.15 |
DisclosureSEC source: 0001127602-24-027217 · form4.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 22:01 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Tax withholdingCommon Stock | 4,304 | $162.05 | $697,463.20 |
DisclosureSEC source: 0001127602-24-003173 · form4.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,963 Read SEC document |
| January 25, 2024 Filed Jan 29, 2024 22:05 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 63,997 | $0.00 Strike: $167.42 | $0.00 |
DisclosureSEC source: 0001127602-24-002469 · form4.xml · derivative · entry 3 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,997 Underlying: Common Stock · 63,997 shares Expires 2034-01-25 F2 · derivative.exercise_date: The option becomes exercisable in four equal installments beginning on January 25, 2025. Read SEC document |
| January 25, 2024 Filed Jan 29, 2024 22:05 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 14,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-002469 · form4.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,267 F1 · shares: Award of restricted stock units pursuant to 2009 Long-Term Incentive Plan. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:56 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Tax withholdingCommon Stock | 5,064 | $173.13 | $876,730.32 |
DisclosureSEC source: 0001127602-23-003141 · form4.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,793 Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 00:16 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 51,824 | $0.00 Strike: $174.10 | $0.00 |
DisclosureSEC source: 0001127602-23-002727 · form4.xml · derivative · entry 4 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,824 Underlying: Common Stock · 51,824 shares Expires 2033-01-26 F2 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 26, 2024. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 00:16 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 13,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-002727 · form4.xml · nonDerivative · entry 2 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,857 F1 · shares: Award of restricted stock units pursuant to 2009 Long-Term Incentive Plan. Read SEC document |
| August 04, 2022 Filed Jan 31, 2023 00:16 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GiftCommon Stock | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-002727 · form4.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 00:50 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Tax withholdingCommon Stock | 3,658 | $177.29 | $648,526.82 |
DisclosureSEC source: 0001127602-22-002634 · form4.xml · nonDerivative · entry 6 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,930 Read SEC document |
| January 27, 2022 Filed Feb 1, 2022 00:50 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 47,734 | $0.00 Strike: $174.81 | $0.00 |
DisclosureSEC source: 0001127602-22-002634 · form4.xml · derivative · entry 7 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,734 Underlying: Common Stock · 47,734 shares Expires 2032-01-27 F4 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 27, 2023. Read SEC document |
| January 27, 2022 Filed Feb 1, 2022 00:50 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 10,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-002634 · form4.xml · nonDerivative · entry 5 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,588 F3 · shares: Award of restricted stock units pursuant to 2009 Long-Term Incentive Plan. Read SEC document |
| October 18, 2021 Filed Feb 1, 2022 00:50 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GiftCommon Stock | 33,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-002634 · form4.xml · nonDerivative · entry 4 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · SLAT Disclosed balance after: 33,994 F2 · kind: Represents a gift from reporting person's spouse to a SLAT for benefit of children, of which reporting person is a trustee; beneficial ownership by reporting person disclaimed. Read SEC document |
| October 18, 2021 Filed Feb 1, 2022 00:50 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GiftCommon Stock | 33,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-002634 · form4.xml · nonDerivative · entry 3 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 550 F2 · kind: Represents a gift from reporting person's spouse to a SLAT for benefit of children, of which reporting person is a trustee; beneficial ownership by reporting person disclaimed. Read SEC document |
| September 08, 2021 Filed Feb 1, 2022 00:50 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GiftCommon Stock | 34,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-002634 · form4.xml · nonDerivative · entry 2 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 34,544 F1 · kind: Represents a gift from reporting person to the reporting person's spouse; beneficial ownership by reporting person disclaimed. Read SEC document |
| September 08, 2021 Filed Feb 1, 2022 00:50 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GiftCommon Stock | 34,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-002634 · form4.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,655 F1 · kind: Represents a gift from reporting person to the reporting person's spouse; beneficial ownership by reporting person disclaimed. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:34 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 33,995 | $0.00 Strike: $104.41 | $0.00 |
DisclosureSEC source: 0001127602-21-005033 · form4.xml · derivative · entry 5 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,996 Underlying: Common Stock · 33,995 shares Expires 2029-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 25, 2020. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:34 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 11,095 | $0.00 Strike: $110.15 | $0.00 |
DisclosureSEC source: 0001127602-21-005033 · form4.xml · derivative · entry 4 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,921 Underlying: Common Stock · 11,095 shares Expires 2028-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in four equal annual installments beginning on January 25, 2019. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:34 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 45,090 | $174.28 | $7,858,190.51 |
DisclosureSEC source: 0001127602-21-005033 · form4.xml · nonDerivative · entry 3 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,135 F1 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $173.84 to $174.64. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:34 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionCommon Stock | 33,995 | $104.41 | $3,549,417.95 |
DisclosureSEC source: 0001127602-21-005033 · form4.xml · nonDerivative · entry 2 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:34 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionCommon Stock | 11,095 | $110.15 | $1,222,114.25 |
DisclosureSEC source: 0001127602-21-005033 · form4.xml · nonDerivative · entry 1 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 22:46 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 27,665 | $0.00 Strike: $110.15 | $0.00 |
DisclosureSEC source: 0001127602-21-004234 · form4.xml · derivative · entry 7 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,016 Underlying: Common Stock · 27,665 shares Expires 2028-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option became exercisable in four equal annual installments beginning on January 25, 2019. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 22:46 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 433 | $174.70 | $75,647.05 |
DisclosureSEC source: 0001127602-21-004234 · form4.xml · nonDerivative · entry 6 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,135 F5 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $174.66 to $174.75. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 22:46 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 2,866 | $174.01 | $498,720.68 |
DisclosureSEC source: 0001127602-21-004234 · form4.xml · nonDerivative · entry 5 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,568 F4 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $173.645 to $174.565. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 22:46 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 4,551 | $173.18 | $788,144.00 |
DisclosureSEC source: 0001127602-21-004234 · form4.xml · nonDerivative · entry 4 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,434 F3 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $172.49 to $173.47. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 22:46 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | SaleCommon Stock | 7,637 | $172.02 | $1,313,721.32 |
DisclosureSEC source: 0001127602-21-004234 · form4.xml · nonDerivative · entry 3 Lizardi Rafael R · CIK 0001691660 · Sr. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,985 F2 · price: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $171.47 to $172.46. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.